Home artivio.eu

Author: artivio.eu

Post
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch

Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch

Developers have married gene-modulating oligonucleotides with the targeted precision of antibodies, and the first filings using such conjugates in Duchenne muscular dystrophy are imminent. Author information Authors and Affiliations Dublin, Ireland Cormac Sheridan Rights and permissions About this article Cite this article Sheridan, C. Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to...

Post
‘Less pitching, more listening’: What Amazon is really doing at

‘Less pitching, more listening’: What Amazon is really doing at

By Seb Joseph  •  January 5, 2026  • Ivy Liu Keep up to date with Digiday’s annual coverage of the Consumer Electronics Show (CES) in Las Vegas. More from the series → CES has become the ad industry’s first real gut check of the year. For Amazon’s ad team, that means less pitching and more